Inpharma Weekly

, Volume 1624, Issue 1, pp 21–21 | Cite as

Sorafenib approved for liver cancer in Canada

Media release
  • 5 Downloads

Keywords

Carcinoma Cancer Patient Hepatocellular Carcinoma Drug Therapy Sorafenib 

Copyright information

© Adis International Ltd 2008

Personalised recommendations